Justpolma-P Tablet contains Polmacoxib 2mg and Paracetamol 325mg, combining the therapeutic effects of a selective COX-2 inhibitor and an analgesic-antipyretic agent. Polmacoxib, a novel nonsteroidal anti-inflammatory drug (NSAID), selectively inhibits cyclooxygenase-2 (COX-2), thereby reducing inflammation and pain with a lower risk of gastrointestinal side effects compared to traditional NSAIDs. Paracetamol, also known as acetaminophen, provides effective analgesic and antipyretic action by inhibiting prostaglandin synthesis in the central nervous system. This combination is indicated for the management of mild to moderate pain associated with musculoskeletal disorders, osteoarthritis, rheumatoid arthritis, and postoperative pain, as well as for reducing fever. Justpolma-P Tablet offers rapid onset of pain relief with sustained anti-inflammatory benefits, improving patient compliance and comfort. It is generally well tolerated; however, caution is advised in patients with hepatic or renal impairment, cardiovascular disease, or gastrointestinal disorders. Concomitant use with other NSAIDs or hepatotoxic drugs should be avoided. Dosage should be individualized based on clinical response and patient tolerance. Consultation with a healthcare professional is recommended before initiating therapy to ensure safe and effective use.